Standard BioTools Inc. (FRA:FLB)

Market Cap	303.81M -20.8%
Revenue (ttm)	72.68M -6.2%
Net Income	-63.79M
EPS	-0.17
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	7
Open	0.8200
Previous Close	0.8200
Day's Range	0.8200 - 0.8200
52-Week Range	0.8000 - 1.4200
Beta	n/a
RSI	35.80
Earnings Date	May 5, 2026

About Standard BioTools

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneo...

• Industry: Laboratory Analytical Instruments
• Founded: 1999
• Employees: 387
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FLB

Financial Performance

In 2025, Standard BioTools's revenue was $85.33 million, a decrease of -6.24% compared to the previous year's $91.01 million. Losses were -$74.90 million, -59.49% less than in 2024.

Financial numbers in USD